Drug recall · March 23, 2022
0.9% Sodium Chloride Injection USP recall
Why: Lack of sterility assurance: leaking bags
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
0.9% Sodium Chloride Injection USP, 250 mL Excel Container, Rx only, B. Braun Medical Inc., Bethlehem, PA, NDC 0264-7800-20
- Lots / codes
Lot #: J1E086, J1E204, J1E213, Exp 5/31/2023; J1H137, J1H138, Exp 6/30/2023
- Quantity
- 33,742 bags
- Company
- B. Braun Medical, Inc., Allentown, PA
- Distribution
- USA Nationwide
- Initiated
- February 25, 2022 · Voluntary: Firm initiated
- Classified
- March 17, 2022
- Reported
- March 23, 2022
- Ended
- March 16, 2023
- How notified
- Other
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium chloride
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.